Press Releases
-
![]()
TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer
9 October 2026
-
![]()
Promising Preclinical Data
28 January 2026
-
![]()
Tetra Pharm Technologies Relocates to Copenhagen Towers
18 September 2024
-
![]()
Partnership to Accelerate the Discovery of Novel Drug Candidates
30 May 2024
-
![]()
Tetra Pharm Technologies and Glysious Announce Collaboration
24 April 2024
-
![]()
Compound for appetite suppression, TPT0701, advances into preclinical testing
8 February 2024
-
![]()
Conclusion of preclinical testing of TPT0301
6 September 2023
-
![]()
Inaugurates new R&D, manufacturing and production facility
16 August 2023
-
![4-dages arbejdsuge for at fremme medarbejdertrivsel og produktivitet]()
4-dages arbejdsuge for at fremme medarbejdertrivsel
2 August 2023
-
![]()
Successful In-Vitro drug release test of new analgesic compound
13 June 2023
-
![]()
Tetra Pharm Technologies strengthens management board
16 May 2023
-
![]()
Tetra Pharm Technologies launches first product in Germany
3 May 2023
-
![]()
Tetra Pharm Technologies secures €9 million in Series A Round
26 January 2023
